amprenavir has been researched along with Invasiveness, Neoplasm in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baldi, A; Chirianni, A; De Luca, A; Esposito, V; Galati, R; Manente, L; Montesarchio, V; Pagliano, P; Parrella, G; Parrella, R; Spugnini, EP; Verdina, A; Viglietti, R | 1 |
1 other study(ies) available for amprenavir and Invasiveness, Neoplasm
Article | Year |
---|---|
Amprenavir inhibits the migration in human hepatocarcinoma cell and the growth of xenografts.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Apoptosis; Carbamates; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Cell Survival; Enzyme Activation; Furans; HIV Protease Inhibitors; Humans; Liver Neoplasms; Male; Matrix Metalloproteinase 2; Mice; Mice, Nude; Neoplasm Invasiveness; Proto-Oncogene Proteins c-akt; Sulfonamides; Xenograft Model Antitumor Assays | 2013 |